These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3840838)

  • 1. Detection of 5-S-cysteinyldopamine in human brain.
    Rosengren E; Linder-Eliasson E; Carlsson A
    J Neural Transm; 1985; 63(3-4):247-53. PubMed ID: 3840838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution and rates of formation of catecholamines in several regions of bovine brain.
    Kindwall EP; Weiner N
    J Neurochem; 1966 Dec; 13(12):1523-31. PubMed ID: 5962032
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dopamine concentration in the nigrostriatal system during electrical stimulation of the head of the caudate nucleus].
    Bazhenova SI; Saul'skaia NB
    Fiziol Zh SSSR Im I M Sechenova; 1979 Apr; 65(4):521-6. PubMed ID: 456666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oxotremorine after nigrostriatal lesions in rats.
    Westermann KH; Oelszner W; Funk KF; Staib AH
    Pol J Pharmacol Pharm; 1975; 27(4):413-7. PubMed ID: 1166022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D-1 receptors in the parkinsonian brain.
    Rinne JO; Rinne JK; Laakso K; Lönnberg P; Rinne UK
    Brain Res; 1985 Dec; 359(1-2):306-10. PubMed ID: 2934111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
    Fornstedt B; Bergh I; Rosengren E; Carlsson A
    J Neurochem; 1990 Feb; 54(2):578-86. PubMed ID: 2105377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
    Quirion R; Gaudreau P; Martel JC; St-Pierre S; Zamir N
    Brain Res; 1985 Apr; 331(2):358-62. PubMed ID: 2859094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA content and glutamic acid decarboxylase activity in brain of Huntington's chorea patients and control subjects.
    Urquhart N; Perry TL; Hansen S; Kennedy J
    J Neurochem; 1975 May; 24(5):1071-5. PubMed ID: 124764
    [No Abstract]   [Full Text] [Related]  

  • 9. Homovanillic acid in different regions of the human brain: attempt at localizing central dopamine fibres.
    Hornykiewicz O; Lisch HJ; Springer A
    Brain Res; 1968 Dec; 11(3):662-71. PubMed ID: 5712014
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain.
    De Keyser J; De Backer JP; Ebinger G; Vauquelin G
    J Neurol Sci; 1985 Nov; 71(1):119-27. PubMed ID: 2935593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior to posterior variations in the concentration of somatostatin-like immunoreactivity in human basal ganglia.
    Davies P; Josef J; Thompson A
    Brain Res Bull; 1981 Oct; 7(4):365-8. PubMed ID: 6117352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional distribution of gamma-aminobutyric acid (GABA) in brain of the rhesus monkey.
    Fahn S; Côté LJ
    J Neurochem; 1968 Mar; 15(3):209-13. PubMed ID: 4966292
    [No Abstract]   [Full Text] [Related]  

  • 13. [Catecholamines distribution in caudate nucleus, putamen, pallidum and black substance of the rat brain].
    Boissier JR; Portmann EM; Tillement JP
    C R Acad Hebd Seances Acad Sci D; 1973 Jan; 276(1):89-91. PubMed ID: 4196505
    [No Abstract]   [Full Text] [Related]  

  • 14. Light and electron microscopic localization of immunoreactive Leu-enkephalin in the monkey basal ganglia.
    DiFiglia M; Aronin N; Martin JB
    J Neurosci; 1982 Mar; 2(3):303-20. PubMed ID: 6121017
    [No Abstract]   [Full Text] [Related]  

  • 15. Catecholamine topochemistry in human basal ganglia. Comparison between normal and Alzheimer brains.
    Nyberg P; Adolfsson R; Hardy JA; Nordberg A; Wester P; Winblad B
    Brain Res; 1985 Apr; 333(1):139-42. PubMed ID: 3995281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of DARPP-32 in the basal ganglia: an electron microscopic study.
    Ouimet CC; Greengard P
    J Neurocytol; 1990 Feb; 19(1):39-52. PubMed ID: 2191086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active peptides in substance P preparations from cortex, globus pallidus and substantia nigra of human brains].
    Baldauf J; Harnacke P; Zetler G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):231-41. PubMed ID: 4239251
    [No Abstract]   [Full Text] [Related]  

  • 18. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.
    Bird ED; Iversen LL
    Brain; 1974 Sep; 97(3):457-72. PubMed ID: 4157009
    [No Abstract]   [Full Text] [Related]  

  • 19. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
    Fornstedt B; Rosengren E; Carlsson A
    Neuropharmacology; 1986 Apr; 25(4):451-4. PubMed ID: 3086766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-correlated loss of dopaminergic binding sites in human basal ganglia.
    Severson JA; Marcusson J; Winblad B; Finch CE
    J Neurochem; 1982 Dec; 39(6):1623-31. PubMed ID: 7142992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.